TrialHuman vaccines & immunotherapeutics2022

Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults.

Javier Díez-Domingo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.